(Q53542638)

English

Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group. (English)

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

1 reference

based on heuristic

inferred from title

medroxyprogesterone acetate

1 reference

based on heuristic

inferred from title

author name string

Kloke O

1

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Klaassen U

2

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Oberhoff C

3

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Hartwich G

4

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Szanto J

5

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Wolf E

6

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Heckmann M

7

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Huhn R

8

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Stephan L

9

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Schnepper U

10

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Donsbach GM

11

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Bechtel C

12

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Rudolph R

13

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Berke A

14

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Borquez D

15

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Hawig I

16

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Hirche H

17

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Schindler AE

18

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Seeber S

19

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Becher R

20

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

55

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

1

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

51-59

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

https://scigraph.springernature.com/pub.10.1023/a:1006169012544

0 references

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Weekly doxorubicin with or without high-dose medroxyprogesterone acetate in hormone-resistant advanced breast cancer. A randomised study. The Norwegian Breast Cancer Group.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Planning the size and duration of a clinical trial studying the time to some critical event

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer--a lesson from the real world--the Swiss Group for Clinical Cancer Research SAKK

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for metastatic breast cancer--when is enough enough?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1006169012544

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/10472779

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53542638&oldid=1562743340"